Orion Files New Stalevo Suit After Sun Tweaks ANDA

Law360, New York (February 12, 2008, 12:00 AM EST) -- Finnish drugmaker Orion Corp. filed another patent infringement suit against Sun Pharmaceutical Industries Ltd. on Thursday to protect the market for its Parkinson's drug Stalevo, after Sun amended a previously filed abbreviated new drug application to include a challenge to another patent.

When Orion filed suit against Sun last week in the U.S. District Court for the Northern District of New Jersey, it marked the second time Orion had sued Sun over Stalevo in the same court since November 2007.

But while the two suits are...
To view the full article, register now.